Abstract:Summary Background Due to the national dynamic zero-COVID strategy in China, there were no persistent local transmissions of SARS-CoV-2 in Beijing before December, 2022. However, imported cases have been frequently detected over the past 3 years. With soaring growth in the number of COVID-19 cases in China recently, there are concerns that there might be an emergence of novel SARS-CoV-2 variants. Routine surveillance of viral genomes has been carried out in Beijing over the last 3 years. Spatiotemporal analyses of recent viral genome sequences compared with that of global pooled and local data are crucial for the global response to the ongoing COVID-19 pandemic. Methods We routinely collected respiratory samples covering both imported and local cases in Beijing for the last 3 years (of which the present study pertains to samples collected between January and December, 2022), and then randomly selected samples for analysis. Next-generation sequencing was used to generate the SARS-CoV-2 genomes. Phylogenetic and population dynamic analyses were performed using high-quality complete sequences in this study. Findings We obtained a total of 2994 complete SARS-CoV-2 genome sequences in this study, among which 2881 were high quality and were used for further analysis. From Nov 14 to Dec 20, we sequenced 413 new samples, including 350 local cases and 63 imported cases. All of these genomes belong to the existing 123 Pango lineages, showing there are no persistently dominant variants or novel lineages. Nevertheless, BA.5.2 and BF.7 are currently dominant in Beijing, accounting for 90% of local cases since Nov 14 (315 of 350 local cases sequenced in this study). The effective population size for both BA.5.2 and BF.7 in Beijing increased after Nov 14, 2022. Interpretation The co-circulation of BF.7 and BA.5.2 has been present in the current outbreak since Nov 14, 2022 in Beijing, and there is no evidence that novel variants emerged. Although our data were only from Beijing, the results could be considered a snapshot of China, due to the frequent population exchange and the presence of circulating strains with high transmissibility. Funding National Key Research and Development Program of China and Strategic Priority Research Program of the Chinese Academy of Sciences. Translation For the Chinese translation of the abstract see Supplementary Materials section.

A regional genomic surveillance program is implemented to monitor the occurrence and emergence of SARS-CoV-2 variants in Yubei District, China

Genomic Surveillance for SARS-CoV-2 — China, September 26, 2022 to January 29, 2023

Evaluation and Prediction of the COVID-19 Variations at Different Input Population and Quarantine Strategies, a Case Study in Guangdong Province, China

Genomic epidemiology reveals early transmission of SARS-CoV-2 and mutational dynamics in Nanning, China

Genomic evolution of BA.5.2 and BF.7.14 derived lineages causing SARS-CoV-2 outbreak at the end of 2022 in China

Prevalence and diversity of imported severe acute respiratory syndrome coronavirus 2 variants in China, 2021–2022

Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis

Genomic Surveillance of COVID-19 Cases in Beijing.

Prevalence of SARS-CoV-2 Omicron Variants and Epidemiological Characteristics of Subvariant XBB Infections in Pudong New Area,Shanghai During January-June 2023

Genetic Surveillance of Five SARS-CoV-2 Clinical Samples in Henan Province Using Nanopore Sequencing

Identification of SARS-CoV-2 Variants and Their Clinical Significance in Hefei, China

Global landscape of SARS-CoV-2 genomic surveillance and data sharing

Spatiotemporal analysis of imported and local dengue virus and cases in a metropolis in Southwestern China, 2013-2022

Trends of SARS-CoV-2 Infection in Rural Area in Sentinel Community-Based Surveillance — China, December 2022 to January 2023

Global Landscape of SARS-CoV-2 Genomic Surveillance, Public Availability Extent of Genomic Data, and Epidemic Shaped by Variants.

Landscape of SARS-CoV-2 genomic surveillance, public availability extent of genomic data, and epidemic shaped by variants: a global descriptive study

Characteristics of SARS-CoV-2 Omicron BA.5 variants in Shanghai after ending the zero-COVID policy in December 2022: a clinical and genomic analysis

Primary Assessment of the Diversity of Omicron Sublineages and the Epidemiologic Features of Autumn/winter 2022 COVID-19 Wave in Chinese Mainland.

Tracking the prevalence and emergence of SARS-CoV-2 variants of concern using a regional genomic surveillance program

Molecular epidemiology and population immunity of SARS-CoV-2 in Guangdong (2022–2023) following a pivotal shift in the pandemic

Epidemiological, Clinical, and Virological Characteristics of 465 Hospitalized Cases of Coronavirus Disease 2019 (COVID-19) from Zhejiang Province in China